Strategic Design and Optimization of Inorganic Sorbents For Cesium, Strontium and Actinides

The basic science goal in this project identifies structure/affinity relationships for selected radionuclides and existing sorbents. The task will apply this knowledge to the design and synthesis of new sorbents that will exhibit increased affinity for cesium, strontium and actinide separations. The target problem focuses on the treatment of high-level nuclear wastes. The general approach can likewise be applied to nonradioactive separations

The Effect of Statin Therapy on Heart Failure Events: A Collaborative Meta-Analysis of Unpublished Data from Major Randomized Trials

Aims: The effect of statins on risk of heart failure (HF) hospitalization and HF death remains uncertain. We aimed to establish whether statins reduce major HF events. Methods and results: We searched Medline, EMBASE, and the Cochrane Central Register of Controlled Trials for randomized controlled endpoint statin trials from 1994 to 2014. Collaborating trialists provided unpublished data from adverse event reports. We included primary- and secondary-prevention statin trials with \u3e1000 participants followed for \u3e1 year. Outcomes consisted of first non-fatal HF hospitalization, HF death and a composite of first non-fatal HF hospitalization or HF death. HF events occurring(MI) were excluded. We calculated risk ratios (RR) with fixed-effects meta-analyses. In up to 17 trials with 132 538 participants conducted over 4.3 [weighted standard deviation (SD) 1.4] years, statin therapy reduced LDL-cholesterol by 0.97 mmol/L (weighted SD 0.38 mmol/L). Statins reduced the numbers of patients experiencing non-fatal HF hospitalization (1344/66 238 vs. 1498/66 330; RR 0.90, 95% confidence interval, CI 0.84–0.97) and the composite HF outcome (1234/57 734 vs. 1344/57 836; RR 0.92, 95% CI 0.85–0.99) but not HF death (213/57 734 vs. 220/57 836; RR 0.97, 95% CI 0.80–1.17). The effect of statins on first non-fatal HF hospitalization was similar whether this was preceded by MI (RR 0.87, 95% CI 0.68–1.11) or not (RR 0.91, 95% CI 0.84–0.98). Conclusion: In primary- and secondary-prevention trials, statins modestly reduced the risks of non-fatal HF hospitalization and a composite of non-fatal HF hospitalization and HF death with no demonstrable difference in risk reduction between those who suffered an MI or not

A Bow Shock Nebula Around a Compact X-Ray Source in the Supernova Remnant IC443

We present spectra and high resolution images of the hard X-ray feature along the southern edge of the supernova remnant IC443. Data from the Chandra X-ray Observatory reveal a comet-shaped nebula of hard emission, which contains a softer point source at its apex. We also present 20cm, 6cm, and 3.5cm images from the Very Large Array that clearly show the cometary nebula. Based on the radio and X-ray morphology and spectrum, and the radio polarization properties, we argue that this object is a synchrotron nebula powered by the compact source that is physically associated with IC443. The spectrum of the soft point source is adequately but not uniquely fit by a black body model (kT=0.71 +/- 0.08 keV, L=(6.5 +/- 0.9) * 10^31 erg/s). The cometary morphology of the nebula is the result of the supersonic motion of the neutron star (V_NS=250 +/- 50 km/s), which causes the relativistic wind of the pulsar to terminate in a bow shock and trail behind as a synchrotron tail. This velocity is consistent with an age of 30,000 years for the SNR and its associated neutron star.Comment: 9 pages, 5 figures, accepted for publication in the ApJ Letter

Redetermination of bis(2-amino-3-hydroxy-1-phenylpropanolato-κ 2 N , O 1 )(ethylenediamine-κ 2 N , N ′)cobalt(III) iodide monohydrate

New data for the title complex, [Co(C9,H12NO 2)2(C2H8N2)]I-H 2O, allow the modelling of previously unresolved disorder [Wardeska et al. (1979). Inorg. Chem. 18, 1641-1648] in the ethylenediamine ligand coordinated to the octahedral cation

SYNTHESIS, AB INITIO STRUCTURE DETERMINATION, AND CHARACTERIZATION OF MANGANESE(III) PHENYL PHOSPHONATES

ABSTRACT , space group P1, and Z ϭ 2. The final agreement factors were R WP ϭ 12.8%, R P ϭ 9.1%, and R F ϭ 3.2%. There are 22 non-hydrogen atoms in the asymmetric part of the unit cell, and the positional parameters were refined with the help of soft constraints. The octahedral manganese coordination spheres are distorted due to the Jahn-Teller effect. The structure of this organic-inorganic compound is layered. The thermal behavior of Mn(HO 3 PC 6 H 5 )(O 3 PC 6 H 5 )⅐H 2 O was studied and its thermal decomposition product was identified. © 1998 Elsevier Science Lt

Development of Improved Sorbents for Radiochemical Separations at the SRS

High-level nuclear waste produced from fuel reprocessing operations at the Savannah River Site (SRS) requires pretreatment to remove {sup 137}Cs, {sup 90}Sr and alpha-emitting radionuclides (i.e., actinides) prior to disposal. Separation processes planned at SRS include caustic side solvent extraction, for {sup 137}Cs removal, and ion exchange/sorption of {sup 90}Sr and alpha-emitting radionuclides with monosodium titanate (MST). The predominant alpha-emitting radionuclides in the highly alkaline waste solutions include plutonium isotopes {sup 238}Pu, {sup 239}Pu and {sup 240}Pu. This paper describes results from a project to produce sorbents that exhibit increased removal kinetics and capacity for {sup 90}Sr and alpha-emitting radionuclides versus that of the baseline MST material. Testing indicated that MST samples prepared in the presence of organic-based templating agents showed limited improvements in performance compared to the baseline MST. We observed significantly improved plutonium and neptunium removal performance with MST samples prepared upon the addition of a proprietary reagent. The modified MST offers the possibility of increased throughput and reduced solids handling in waste processing facilities at the SRS

Alkaline-earth phosphonate MOFs with reversible hydration-dependent fluorescence

A new rigid tritopic phosphonic ligand, 2,4,6-tris(4-phosphonophenyl)pyridine (H6L), was synthesized and used to assemble isostructural barium (1) and strontium (2) phosphonate metal organic frameworks that exhibit fully reversible and selective water-dependent fluorescence red-shift at room temperature

Synthesis and electrochemical behavior of ceramic cation-exchange membranes based on zirconium phosphate

Cation-exchange membranes made exclusively from ceramic materials have been synthesized by means of the impregnation of microporous ceramic supports with zirconium phosphate. Changes in the pore size distribution and total pore volume of the supports were provoked by the addition of starch as pore former in the fabrication procedure. This allowed the production of supports with increased effective electrical conductivities and with larger pores available for the zirconium phosphate deposition. An improved functionality for the exchange of cations was given to the ceramic membranes by means of their impregnation with the active particles of zirconium phosphate. The ion-exchange properties of the membranes were increased with further impregnation cycles and the resulting current voltage curves showed a similar shape to that typical of commercial polymeric ion-exchange membranes. The production of ionexchange membranes with increased chemical and radiation stability will broaden their applicability for the treatment of specific industrial waste waters, which are very aggressive for the current commercial ion-exchange membranes.Manuel-Cesar Marti-Calatayud wants to express his gratitude to Universitat Politecnica de Valencia for a postgraduate grant (Ref. 2010-12). S. Sales would like to express her gratitude to Ministerio de Ciencia e Investigacion (Spain) for a postgraduate grant (AP2009-4409). This work was supported by Ministerio de Ciencia e Innovacion (Spain) with the project numbers CTQ2008-06750-C02-01/PPQ and CTQ2008-06750-C02-02/PPQ.Martí Calatayud, MC.; García Gabaldón, M.; Pérez-Herranz, V.; Sales, S.; Mestre, S. (2013). Synthesis and electrochemical behavior of ceramic cation-exchange membranes based on zirconium phosphate. Ceramics International. 39(4):4045-4054. https://doi.org/10.1016/j.ceramint.2012.10.255S4045405439

Promoting Effect of Layered Titanium Phosphate on the Electrochemical and Photovoltaic Performance of Dye-Sensitized Solar Cells

We reported a composite electrolyte prepared by incorporating layered α-titanium phosphate (α-TiP) into an iodide-based electrolyte using 1-ethyl-3-methylimidazolium tetrafluoroborate(EmimBF4) ionic liquid as solvent. The obtained composite electrolyte exhibited excellent electrochemical and photovoltaic properties compared to pure ionic liquid electrolyte. Both the diffusion coefficient of triiodide (I3−) in the electrolyte and the charge-transfer reaction at the electrode/electrolyte interface were improved markedly. The mechanism for the enhanced electrochemical properties of the composite electrolyte was discussed. The highest conversion efficiency of dye-sensitized solar cell (DSSC) was obtained for the composite electrolyte containing 1wt% α-TiP, with an improvement of 58% in the conversion efficiency than the blank one, which offered a broad prospect for the fabrication of stable DSSCs with a high conversion efficiency

Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy

<p>Background: Statin therapy reduces the risk of occlusive vascular events, but uncertainty remains about potential effects on cancer. We sought to provide a detailed assessment of any effects on cancer of lowering LDL cholesterol (LDL-C) with a statin using individual patient records from 175,000 patients in 27 large-scale statin trials.</p> <p>Methods and Findings: Individual records of 134,537 participants in 22 randomised trials of statin versus control (median duration 4.8 years) and 39,612 participants in 5 trials of more intensive versus less intensive statin therapy (median duration 5.1 years) were obtained. Reducing LDL-C with a statin for about 5 years had no effect on newly diagnosed cancer or on death from such cancers in either the trials of statin versus control (cancer incidence: 3755 [1.4% per year [py]] versus 3738 [1.4% py], RR 1.00 [95% CI 0.96-1.05]; cancer mortality: 1365 [0.5% py] versus 1358 [0.5% py], RR 1.00 [95% CI 0.93–1.08]) or in the trials of more versus less statin (cancer incidence: 1466 [1.6% py] vs 1472 [1.6% py], RR 1.00 [95% CI 0.93–1.07]; cancer mortality: 447 [0.5% py] versus 481 [0.5% py], RR 0.93 [95% CI 0.82–1.06]). Moreover, there was no evidence of any effect of reducing LDL-C with statin therapy on cancer incidence or mortality at any of 23 individual categories of sites, with increasing years of treatment, for any individual statin, or in any given subgroup. In particular, among individuals with low baseline LDL-C (<2 mmol/L), there was no evidence that further LDL-C reduction (from about 1.7 to 1.3 mmol/L) increased cancer risk (381 [1.6% py] versus 408 [1.7% py]; RR 0.92 [99% CI 0.76–1.10]).</p> <p>Conclusions: In 27 randomised trials, a median of five years of statin therapy had no effect on the incidence of, or mortality from, any type of cancer (or the aggregate of all cancer).</p&gt